This is not the report of Motilal Oswal. Instead this is the result of query which was developed by the qualities given by Raamdeo Agarwal.
RJ blog runs mainly on euphoria. To put it in the words of Daniel Kahneman, its our System 1 is in work along with Endowment effect.
Few months back, Motilal Oswal came up with Mid to Mega report (which is mainly contributed by the ideas of Raamdeo). During the same time, Mr. Motilal in an another interview in ET Now said we are looking at Lincoln Pharma.
Now people started attributing (including RJ blog) saying that, Motilal Oswal recommend Lincoln as their Mid to Mega recommendations.
Few flaws to be observed here:
1) Unlike the previous report on 100 baggers, Mr. Raamdeo didn't recommended any stock in this latest Mid to Mega report.
2) Motilal never said that they are recommending it as part of Mid to Mega. He just said that they are looking into this company. People attributed both - Because both happened at same point of time.
3) And most important one - Lincoln Pharma isn't even a Mid cap company. It was sub 300 Cr company at that time. People forgot to question (even RJ blog) that, How come a Small Cap company can be recommended in a Mid to Mega example.
All I am saying is, lets not get into first conclusion bias and also not get carried away by this big institutions and popular blogs. They all have their own vested interest there.
Disclosure: Invested from past 8 months and did partial exit recently.